Impact of intracoronary reinfusion of bone marrow-derived mononuclear progenitor cells on cardiopulmonary exercise capacity in patients with chronic postinfarction heart failure

Clinical Research in Cardiology

Volumn 102, Issue 9, 2013, Pages 619-625

  Honold, Joerg ^a   Fischer Rasokat, Ulrich ^a   Seeger, Florian H ^a   Leistner, David ^a   Lotz, Saskia ^a   Dimmeler, Stefanie ^b   Zeiher, Andreas M ^a   Assmus, Birgit ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Bone marrow cells; Cardiopulmonary exercise capacity; Heart failure; Ischaemic cardiomyopathy

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; BONE MARROW; CARDIOPULMONARY EXERCISE TEST; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; INFUSION; ISCHEMIC CARDIOMYOPATHY; LUNG MINUTE VOLUME; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; STEM CELL;

AGED; BIOLOGICAL MARKERS; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; OXYGEN CONSUMPTION; PEPTIDE FRAGMENTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOVERY OF FUNCTION; REGISTRIES; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84883055317     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-013-0574-1     Document Type: Article

References (37)

1. Arena R, Myers J, Abella J et al (2010) Defining the optimal prognostic window for cardiopulmonary exercise testing in patients with heart failure. Circ Heart Fail 3:405-411
2. Arena R, Myers J, Guazzi M (2008) The clinical and research applications of aerobic capacity and ventilatory efficiency in heart failure: an evidence-based review. Heart Fail Rev 13:245-269
3. Assmus B, Fischer-Rasokat U, Honold J et al (2007) Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry. Circ Res 100:1234-1241
4. Assmus B, Honold J, Schachinger V et al (2006) Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 355:1222-1232
5. Baba R, Nagashima M, Goto M et al (1996) Oxygen uptake efficiency slope: a new index of cardiorespiratory functional reserve derived from the relation between oxygen uptake and minute ventilation during incremental exercise. J Am Coll Cardiol 28:1567-1572
6. Balady GJ, Arena R, Sietsema K et al (2010) Clinician's Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation 122:191-225
7. Beaver WL, Wasserman K, Whipp BJ (1986) A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol 60:2020-2027
8. Belardinelli R, Lacalaprice F, Carle F et al (2003) Exercise-induced myocardial ischaemia detected by cardiopulmonary exercise testing. Eur Heart J 24:1304-1313
9. Bristow MR, Saxon LA, Boehmer J et al (2004) Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350:2140-2150
10. Bruce RA, Blackmon JR, Jones JW et al (1963) Exercising testing in adult normal subjects and cardiac patients. Pediatrics 32(SUPPL):742-756
11. Erbs S, Linke A, Schachinger V et al (2007) Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: the Doppler Substudy of the reinfusion of enriched progenitor cells and infarct remodeling in acute myocardial infarction (REPAIR-AMI) trial. Circulation 116:366-374
12. Erbs S, Linke A, Schuler G et al (2006) Intracoronary administration of circulating blood-derived progenitor cells after recanalization of chronic coronary artery occlusion improves endothelial function. Circ Res 98:e48
13. Fischer-Rasokat U, Honold J, Seeger FH et al (2012) Early remodeling processes as predictors of diastolic function 5 years after reperfused acute myocardial infarction and intracoronary progenitor cell application. Clin Res Cardiol: Off J Ger Cardiac Soc 101:209-216
14. Fuchs S, Kornowski R, Weisz G et al (2006) Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease. Am J Cardiol 97:823-829
15. Grines CL, Topol EJ, Bates ER et al (1988) Infarct vessel status after intravenous tissue plasminogen activator and acute coronary angioplasty: prediction of clinical outcome. Am Heart J 115:1-7
16. Hjalmarson A, Goldstein S, Fagerberg B et al (2000) Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA: J Am Med Assoc 283:1295-1302
17. Hollenberg M, Tager IB (2000) Oxygen uptake efficiency slope: an index of exercise performance and cardiopulmonary reserve requiring only submaximal exercise. J Am Coll Cardiol 36:194-201
18. Honold J, Derosa S, Spyridopoulos I et al (2013) Comparison of the seattle heart failure model and cardiopulmonary exercise capacity for prediction of death in patients with chronic ischemic heart failure and intracoronary progenitor cell application. Clin Cardiol 36:153-159
19. 2-curve (s1) in cardiopulmonary exercise testing is a strong and independent predictor of outcome in patients with previous myocardial infarction. Clin Res Cardiol: Off J Ger Cardiac Soc 97:882-890
20. 2 slope calculated from different time intervals in patients with suspected heart failure. Int J Cardiol 118:350-355
21. Jessup M, Brozena S (2003) Heart failure. N Engl J Med 348:2007-2018
22. Khand A, Gemmel I, Clark AL et al (2000) Is the prognosis of heart failure improving? J Am Coll Cardiol 36:2284-2286
23. Lavie CJ, Milani RV, Mehra MR (2004) Peak exercise oxygen pulse and prognosis in chronic heart failure. Am J Cardiol 93:588-593
24. Leistner DM, Fischer-Rasokat U, Honold J et al (2011) Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy. Clin Res Cardiol: Off J Ger Cardiac Soc 100:925-934
25. Mancini DM, Eisen H, Kussmaul W et al (1991) Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 83:778-786
26. Moss AJ, Zareba W, Hall WJ et al (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877-883
27. Perin EC, Dohmann HF, Borojevic R et al (2003) Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107:2294-2302
28. Perin EC, Dohmann HF, Borojevic R et al (2004) Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation 110:II213-II218
29. Perin EC, Silva GV, Henry TD et al. (2011) A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF). Am Heart J 161:1078-1087 e1073
30. Pitt B, Williams G, Remme W et al (2001) The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study. Cardiovasc Drugs Ther/Spons by Int Soc Cardiovasc Pharmacother 15:79-87
31. Pokushalov E, Romanov A, Chernyavsky A et al (2010) Efficiency of intramyocardial injections of autologous bone marrow mononuclear cells in patients with ischemic heart failure: a randomized study. J Cardiovasc Transl Res 3:160-168
32. Roger VL, Go AS, Lloyd-Jones DM et al (2011) Heart disease and stroke statistics - 2011 update: a report from the American Heart Association. Circulation 123:e18-e209
33. Schachinger V, Assmus B, Britten MB et al (2004) Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 44:1690-1699
34. Strauer BE, Yousef M, Schannwell CM (2010) The acute and long-term effects of intracoronary Stem cell Transplantation in 191 patients with chronic heARt failure: the STAR-heart study. Eur J Heart Fail 12:721-729
35. Strickberger SA, Conti J, Daoud EG et al (2005) Patient selection for cardiac resynchronization therapy: from the council on clinical cardiology subcommittee on electrocardiography and arrhythmias and the quality of care and outcomes research interdisciplinary working group, in collaboration with the heart rhythm society. Circulation 111:2146-2150
36. Van Laethem C, Bartunek J, Goethals M et al (2005) Oxygen uptake efficiency slope, a new submaximal parameter in evaluating exercise capacity in chronic heart failure patients. Am Heart J 149:175-180
37. Yusuf S, Sleight P, Pogue J et al (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators. N Engl J Med 342:145-153